# HEMOBLAST Pivotal Clinical Investigation

> **NCT02780869** · NA · COMPLETED · sponsor: **Biom'Up France SAS** · enrollment: 258 (actual)

## Conditions studied

- Hemostasis

## Interventions

- **DEVICE:** HEMOBLAST Bellows
- **DEVICE:** Absorbable gelatin sponge, USP with thrombin

## Key facts

- **NCT ID:** NCT02780869
- **Lead sponsor:** Biom'Up France SAS
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-18
- **Primary completion:** 2017-02-01
- **Final completion:** 2017-03-27
- **Target enrollment:** 258 (ACTUAL)
- **Last updated:** 2018-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02780869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02780869, "HEMOBLAST Pivotal Clinical Investigation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02780869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*